title: Comment on: Ott et al. Reduction in basal nitric oxide activity causes albuminuria. Diabetes 2011;60:572-576.
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Tsikas
authors.forename: Stefan
authors.initials: S
authors.lastname: Engeli
authors.forename: Jens
authors.initials: J
authors.lastname: Tank
authors.forename: Dirk O
authors.initials: DO
authors.lastname: Stichtenoth
authors.forename: Jens
authors.initials: J
authors.lastname: Jordan
mesh_terms: D000419:Albuminuria / Q000209:etiology*; D000818:Animals; D006801:Humans; D007668:Kidney / Q000187:drug effects; D052250:Nitric Oxide Synthase Type III / Q000037:antagonists & inhibitors*; D013931:Thromboxanes / Q000494:pharmacology; D019323:omega-N-Methylarginine / Q000494:pharmacology*
chemical_list: D013931:Thromboxanes; D019323:omega-N-Methylarginine; C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III